edoc

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure : the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

Maisel, Alan S. and Mueller, Christian and Fitzgerald, Robert and Brikhan, Robert and Hiestand, Brian C. and Iqbal, Navaid and Clopton, Paul and van Veldhuisen, Dirk J.. (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure : the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. European journal of heart failure, Vol. 13, H. 8. pp. 846-851.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004722

Downloads: Statistics Overview

Abstract

Neutrophil gelatinase-associated lipocalin (NGAL) is a measure of acute kidney injury. Renal dysfunction portends significant risk after discharge from acute heart failure (AHF). Thus, a sensitive marker of renal injury might also help to risk stratify HF patients.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Kardiologie > Klinische Outcomeforschung Kardiologie (Müller)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Kardiologie > Klinische Outcomeforschung Kardiologie (Müller)
UniBasel Contributors:Müller, Christian
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Elsevier
ISSN:1388-9842
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:27 Feb 2014 15:45
Deposited On:27 Feb 2014 15:45

Repository Staff Only: item control page